PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
30871035-8	2019	Accordingly, EPA also significantly reduced FASN and ACACA mRNAs in human HepG2 cells.	Eicosapentaenoic Acid	13-16	acetyl-CoA carboxylase alpha	Homo sapiens	53-58	
33801246-9	2021	Moreover, EPA treatment in SUIT-2 cells reduced the expression of de novo lipogenic protein, acetyl coenzyme A carboxylase (ACC)-1, and decreased p-STAT3 and HPS/FGL1 expressions, resulting in the suppression of cell viability.	Eicosapentaenoic Acid	10-13	acetyl-CoA carboxylase alpha	Homo sapiens	93-130	
33801246-11	2021	EPA supplements could potentially inhibit or reduce ACC-1-involved lipogenesis and HPS/FGL1-mediated cell survival in KRAS-mutated pancreatic cancer cells.	Eicosapentaenoic Acid	0-3	acetyl-CoA carboxylase alpha	Homo sapiens	52-57	
34532024-9	2021	The cellular lipid droplets, TG content, and the expression of ACC (by 75%) and SREBP-1c (by 45%) were increased by OA stimulation (p < .05), which was inhibited by EPA treatment.	Eicosapentaenoic Acid	165-168	acetyl-CoA carboxylase alpha	Homo sapiens	63-66